Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Those articles are designed purely as cover for daily short trading and trying to scare shares loose. I can't imagine any smart investor, who bought on Friday on good news, would turn around and sell on this garbage.
Well done! It was rather obvious what was happening last week (i.e. accumulation), with the SP being held around $3.00 and the 5-day MFI rising.
From here on out, news and PRs will come at random and the cabal won't be able to anticipate or prepare. Makes for a very dangerous short game.
And I feel sorry for those with red dollars, who have sold. Those that continue to hold, will be very green in due time.
Maybe, maybe not.
And someone is thanking you for your shares...
Don't kid yourself. The cabal had just as much to do with the rising share price into the 2nd of Nov, as they did with the crash the following day, 3 days BEFORE the conference presentation. I've been here since April 2015; I've experienced it all.
Good for you! I got in at $1.08 (eff. post-split). :)
There's certainly some "funny business" going on this week: MFI is rising while the SP is being tightly controlled around $3.00 and not going lower. It would seem that accumulation is happening in preparation for the next leg up.
Going forward, PRs will come unexpectedly, and the cabal cannot anticipate or prepare.
Agreed. I, personally, don't see it as bad, but not sure how the "market" will initially respond to it. To me, it would indicate that they are going it alone (utilizing a drug mfr/distributor) and not BP.
That's why I hope they announce P3 along with grant or partnership news; otherwise, the market will assume straight dilution.
Potential near-term PRs:
- PK/PD data confirming that the drug is working and safe
- Rett's trial announcement
- Parkinson's data release and planned trial
- Alz P2b/3 + Grant and/or Partnership announcement
And these will ALL BE SURPRISE ANNOUNCEMENTS!
It's encouraging to see the 5-day money-flow indicator moving upward...
That's certainly good to see, even though many of those shares are for their biotech index funds.
MMs and hedgies should know by now that they can't shake shares from longs down at this level. If we won't sell at $7, we sure as hell ain't selling at $3. If they want more shares they should be moving this upward in hopes that a large holder will bail at breakeven.
Ha ha! I always look at the technical indicators; they are valuable in identifying overbought and oversold conditions.
Fundamentals? There are no Fundamentals: no revenue, no EPS, etc. What I believe you're referring to, are the science and clinical data... which are the reasons I remain fully loaded.
Looking at past trends, seems we might languish here for another week or so, in lieu of any news. This will allow the MACD to roll under and the Stochastic to bottom out. Just sayin...
To reiterate Xena's response... the data, especially the monotherapy data, indicated a potential curative effect at 31 wks, but is inconclusive only because of the small 'n'. As expressed in Anavex's PR...
"The study also offered encouraging evidence confirming the previously reported positive trends in some cognitive and biologic measures persisted over a period of approximately 31 weeks.
However, the company clarified that this analysis was based on a relatively small number of subjects receiving a variety of doses. Therefore, the company said that that these findings might not reflect the full potential of ANAVEX 2-73 in treating Alzheimer's disease."
AF and the shorting cabal are responsible for the rapid share price decline. They had a premeditated plan to attack, regardless of what the data showed.
My bag is rather nice and will be even nicer as the company progresses its trials on various indications. I'm up only 3x currently... expect a 10 bagger from here in 6-12 months. Yeah, it's in the BAG!
It IS... until it isn't. Time will tell, but my money's on IS!
Here we go again...
The market's view changed with the Part B results
Are you implying that AF's articles represent the feelings of the "market" and his reference to Anavex's trial as being "garbage" accurate?
As you can see, the market called BS on the company claims and is focusing on the longer term interim results as a "show me". Rightly so.
He's baaaack!
Good move! And remember, heaven forbid we're not above $6 by year end (or April 14), one can recharacterize those shares back to Traditional.
Exactly! Those who say it doesn't exist are likely hooked into the criminal activity.
That's an appropriate label. Though shorting in itself is not illegal, collusion and naked shorting ARE!
For tax-conscious investors...
It would be a great time to convert any Traditional IRA shares to Roth, especially if you're over 59-1/2 (accessibility). If the strategy doesn't work out (heaven forbid), one can always recharacterize back to Traditional, without tax consequences or penalties.
Also, would be a good time to contribute to your Roth and buy AVXL shares. This morning, I sold $13k worth of AVXL shares in my taxable acct at $3.30 (long-term gains), contributed $6500, each, to my and my wife's Roths, then repurchased additional AVXL shares in those respective accts.
I emailed the company's atty yesterday and received the below response...
"Thank you for your email. The Company is equally concerned with the recent trading activity and is taking numerous actions in response to this activity including contacting the regulatory authorities."
Hopefully, we'll see something soon!
I haven't traded any shares, yet. Was thinking about it last Wed, expecting a spike on good news, but the cabal had a different plan (like in Nov) to slam it before the news could be digested.
I don't look at the technicals much; when I do it's usually the slow stochastic and money flow to identify overbought/oversold areas.
Until Anavex can get notoriety with more public demand, we'll continue to be encumbered by the cabal. It will likely require a partnership for that to happen. IMO, by year's end.
mike, you really need to do some serious research on the subject, because it is much bigger than just AF; he's just the tip of the iceberg. He's not the one doing the damage; he's just the most visible part of it.
Thanks. And I'll add... if the SEC is not part of the solution, then it must be that they're part of the problem.
Yep... Cramer helped start it. Nuff said.
Exactly. AF is associated with hedge funds that prey on microcap bios. One is TheStreet.com. It's common knowledge and likely have bought out the SEC.
Of course, shorts established their positions higher; some might have covered and the others are still being assisted by the manipulation of the cabal (many 100-share trades to keep downward pressure on the price).
How can you "know" that the price is going lower, unless you have some insight into the cabal's game plan? You can't know what the majority of retail is doing.
Potential catalysts over the coming weeks:
- PK/PD analysis
- Rett's trial news
- Parkinson's trial news
- Partnership news
- Alz P3 news
Great buy! In the following months, you'll be glad you did!
MANIPULATION! (primarily) The cabal drives the SP of many microcap bios up and down to where ever they want it. They now want to create tremendous fear to shake out as much retail as possible.
Savvy investors will find this as a great buying opportunity before the next catalyst hits.
These things will work out in due time; I have confidence in the company and the science.
Results did not disappoint one bit. Do you actually believe AF and Corey?
Patent extensions can and do occur. Question is if AVXL is working on one for 2-73 monotherapy.